learning Objectives
- To discuss the contemporary challenges in identifying and optimizing management of heart failure
- To review the emerging pharmacotherapies for heart failure
- To discuss the newest HFrEF clinical trial data and their implications on the future of heart failure care
Agenda
| 2:38 | REDUCE-IT and EVAPORATE Trials Update Dr. Lawrence Leiter |
| 13:09 | DECLARE-TIMI 58 Trial Update |
| 27:41 | The ORION Program Dr. Lawrence Leiter |
| 33:29 | DAPA-HF Trial Update Dr. Subodh Verma |
| 49:15 | EMPA-HEART CardioLink 6 Trial Update Dr. Subodh Verma |
Faculty
Dr. Mohammed Al-Omran
MD, MSc, FRCSC
CO-CHAIR
Head of Vascular Surgery,
St. Michael’s Hospital
Professor of Surgery, and, Pharmacology
and Toxicology, University of Toronto,
Toronto, ON
Dr. Lawrence A. Leiter
MD, FRCPC, FACP, FACE, FAHA, FACC
CO-CHAIR
Endocrinologist,
St. Michael’s Hospital;
Professor of Medicine and Nutritional
Sciences, University of Toronto,
Toronto, ON
Dr. Subodh Verma
MD, PhD, FRCSC, FAHA
CO-CHAIR
Cardiac Surgeon, St. Michael’s Hospital;
Professor of Surgery and Pharmacology &
Toxicology, University of Toronto;
Canada Research Chair in Cardiovascular
Surgery, Toronto, ON
Video Information
- Credit:No Credit Available
- Post Date:January 15, 2020
- Expiry Date:N/A
